CCDC124
gene geneOn this page
Also known as Lso2oxs1
Summary
CCDC124 (coiled-coil domain containing 124, HGNC:25171) is a protein-coding gene on chromosome 19p13.11, encoding Coiled-coil domain-containing protein 124 (Q96CT7). Ribosome-binding protein involved in ribosome hibernation: associates with translationally inactive ribosomes and stabilizes the nonrotated conformation of the 80S ribosome, thereby promoting ribosome preservation and storage.
Enables RNA binding activity. Predicted to be involved in transcription by RNA polymerase II. Located in cytosol and plasma membrane.
Source: NCBI Gene 115098 — automated summary from GO annotations (Alliance of Genome Resources).
At a glance
- GWAS associations: 5
- Clinical variants (ClinVar): 49 total
- GTEx eGene: eQTL in 40 tissues, sQTL in 38 (q < 0.05)
- Constraint (gnomAD): pLI 0.02 (LoF-tolerant), LOEUF 0.99 (unconstrained)
- MANE Select transcript:
NM_001136203
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:25171 |
| Approved symbol | CCDC124 |
| Name | coiled-coil domain containing 124 |
| Location | 19p13.11 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | Lso2, oxs1 |
| Ensembl gene | ENSG00000007080 |
| Ensembl biotype | protein_coding |
| OMIM | 621286 |
| Entrez | 115098 |
Gene structure
Transcript identifiers
Ensembl transcripts: 27 — 24 protein_coding, 2 nonsense_mediated_decay, 1 retained_intron
MANE Select: ENST00000445755
Transcript support level (Ensembl TSL; 1 = fully mRNA-supported): TSL 1: 1, TSL 2: 2, TSL 5: 1
ENST00000445755, ENST00000596123, ENST00000597436, ENST00000602080, ENST00000873323, ENST00000873324, ENST00000873325, ENST00000873326, ENST00000873327, ENST00000926054, ENST00000926055, ENST00000926056, ENST00000926057, ENST00000926058, ENST00000926059, ENST00000926060, ENST00000926061, ENST00000926062, ENST00000926063, ENST00000926064, ENST00000926065, ENST00000944720, ENST00001006087, ENST00001006088, ENST00001022889, ENST00001100415, ENST00001137941
RefSeq mRNA: 2 — MANE Select: NM_001136203
NM_001136203, NM_138442
CCDS: CCDS12369
Canonical transcript exons
ENST00000445755 — 5 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000689900 | 17943261 | 17943375 |
| ENSE00001056262 | 17942656 | 17942845 |
| ENSE00001658662 | 17936410 | 17936579 |
| ENSE00001765913 | 17933015 | 17933048 |
| ENSE00003035563 | 17943508 | 17943985 |
Expression profiles
Bgee: expression breadth ubiquitous, 214 present calls, max score 97.45.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 34.4647 / max 209.8827, expressed in 1821 samples.
Highest expression (Bgee): anterior cingulate cortex, gastrocnemius, lower esophagus muscularis layer, lower esophagus, frontal lobe.
Genetic regulation across tissues (GTEx eQTL / sQTL)
CCDC124 is an eGene in GTEx v10 — its expression is genetically regulated (eQTL) in 40 tissues and its splicing (sQTL) in 38 (q < 0.05). Strongest associations first; slope = normalized effect of the lead variant’s alternative allele.
showing 20 of 78 significant tissue × QTL associations:
| Tissue | QTL | q-value | Slope | Lead variant |
|---|---|---|---|---|
| Skin Sun Exposed Lower leg | sqtl | 9.4e-103 | +1.14 | 19:17942531:T:C |
| Thyroid | sqtl | 1.4e-63 | +0.94 | 19:17942531:T:C |
| Lung | sqtl | 5.0e-63 | +0.90 | 19:17942531:T:C |
| Skin Not Sun Exposed Suprapubic | sqtl | 5.1e-63 | +1.03 | 19:17942531:T:C |
| Adipose Subcutaneous | sqtl | 1.4e-61 | +0.95 | 19:17942531:T:C |
| Nerve Tibial | sqtl | 1.5e-60 | +0.96 | 19:17942531:T:C |
| Adipose Visceral Omentum | sqtl | 8.5e-55 | +1.02 | 19:17942531:T:C |
| Cells EBV-transformed lymphocytes | sqtl | 5.1e-47 | +1.17 | 19:17942531:T:C |
| Whole Blood | sqtl | 1.5e-46 | +0.81 | 19:17942531:T:C |
| Breast Mammary Tissue | sqtl | 2.8e-42 | +0.96 | 19:17942531:T:C |
| Colon Transverse | sqtl | 3.3e-37 | +0.96 | 19:17942531:T:C |
| Brain Cerebellar Hemisphere | sqtl | 4.5e-35 | +1.20 | 19:17942531:T:C |
| Brain Frontal Cortex BA9 | sqtl | 2.4e-34 | +1.12 | 19:17942531:T:C |
| Artery Aorta | sqtl | 1.0e-32 | +0.89 | 19:17942531:T:C |
| Brain Cortex | sqtl | 2.3e-32 | +1.13 | 19:17942531:T:C |
| Testis | sqtl | 1.4e-30 | +1.00 | 19:17942531:T:C |
| Brain Anterior cingulate cortex BA24 | sqtl | 2.2e-29 | +1.16 | 19:17942531:T:C |
| Adipose Subcutaneous | eqtl | 8.6e-27 | -0.24 | 19:17934310:G:A |
| Brain Cerebellum | sqtl | 1.7e-26 | +1.05 | 19:17942531:T:C |
| Artery Tibial | eqtl | 1.8e-26 | +0.18 | 19:17939866:T:G |
FANTOM5 promoters
2 alternative TSS:
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 174563 | 32.5623 | 1821 |
| 174564 | 1.9024 | 1081 |
Top tissues by expression
showing 100 of 238 tissues by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| anterior cingulate cortex | UBERON:0009835 | 97.45 | gold quality |
| gastrocnemius | UBERON:0001388 | 97.35 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 97.27 | gold quality |
| lower esophagus | UBERON:0013473 | 97.26 | gold quality |
| right frontal lobe | UBERON:0002810 | 97.20 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 96.99 | gold quality |
| apex of heart | UBERON:0002098 | 96.96 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 96.90 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 96.88 | gold quality |
| right atrium auricular region | UBERON:0006631 | 96.78 | gold quality |
| left coronary artery | UBERON:0001626 | 96.77 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 96.77 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 96.76 | gold quality |
| prefrontal cortex | UBERON:0000451 | 96.64 | gold quality |
| muscle of leg | UBERON:0001383 | 96.60 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 96.51 | gold quality |
| popliteal artery | UBERON:0002250 | 96.50 | gold quality |
| tibial artery | UBERON:0007610 | 96.49 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 96.47 | gold quality |
| ascending aorta | UBERON:0001496 | 96.34 | gold quality |
| aorta | UBERON:0000947 | 96.32 | gold quality |
| thoracic aorta | UBERON:0001515 | 96.30 | gold quality |
| coronary artery | UBERON:0001621 | 96.15 | gold quality |
| amygdala | UBERON:0001876 | 96.10 | gold quality |
| right coronary artery | UBERON:0001625 | 96.08 | gold quality |
| skin of leg | UBERON:0001511 | 96.02 | gold quality |
| hypothalamus | UBERON:0001898 | 95.90 | gold quality |
| mucosa of stomach | UBERON:0001199 | 95.89 | gold quality |
| ectocervix | UBERON:0012249 | 95.82 | gold quality |
| esophagus | UBERON:0001043 | 95.79 | gold quality |
| skin of abdomen | UBERON:0001416 | 95.76 | gold quality |
| body of stomach | UBERON:0001161 | 95.75 | gold quality |
| cardiac atrium | UBERON:0002081 | 95.69 | gold quality |
| putamen | UBERON:0001874 | 95.63 | gold quality |
| heart left ventricle | UBERON:0002084 | 95.57 | gold quality |
| tibial nerve | UBERON:0001323 | 95.49 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 95.36 | gold quality |
| body of uterus | UBERON:0009853 | 95.34 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 95.33 | gold quality |
| caudate nucleus | UBERON:0001873 | 95.31 | gold quality |
| endocervix | UBERON:0000458 | 95.26 | gold quality |
| nucleus accumbens | UBERON:0001882 | 95.14 | gold quality |
| omental fat pad | UBERON:0010414 | 95.12 | gold quality |
| peritoneum | UBERON:0002358 | 95.05 | gold quality |
| esophagus mucosa | UBERON:0002469 | 95.02 | gold quality |
| cardiac ventricle | UBERON:0002082 | 95.00 | gold quality |
| left uterine tube | UBERON:0001303 | 94.96 | gold quality |
| right adrenal gland | UBERON:0001233 | 94.84 | gold quality |
| minor salivary gland | UBERON:0001830 | 94.79 | gold quality |
| spinal cord | UBERON:0002240 | 94.79 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 94.67 | gold quality |
| left adrenal gland | UBERON:0001234 | 94.64 | gold quality |
| right lung | UBERON:0002167 | 94.60 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 94.58 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 94.56 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 94.53 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 94.50 | gold quality |
| transverse colon | UBERON:0001157 | 94.47 | gold quality |
| adipose tissue of abdominal region | UBERON:0007808 | 94.45 | gold quality |
| upper lobe of left lung | UBERON:0008952 | 94.42 | gold quality |
| metanephros cortex | UBERON:0010533 | 94.40 | gold quality |
| ganglionic eminence | UBERON:0004023 | 94.39 | gold quality |
| right ovary | UBERON:0002118 | 94.33 | gold quality |
| granulocyte | CL:0000094 | 94.30 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 94.28 | gold quality |
| stromal cell of endometrium | CL:0002255 | 94.21 | gold quality |
| cortical plate | UBERON:0005343 | 94.20 | gold quality |
| neocortex | UBERON:0001950 | 94.19 | gold quality |
| left ovary | UBERON:0002119 | 94.15 | gold quality |
| frontal cortex | UBERON:0001870 | 94.08 | gold quality |
| body of pancreas | UBERON:0001150 | 94.06 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 93.94 | gold quality |
| monocyte | CL:0000576 | 93.91 | gold quality |
| adenohypophysis | UBERON:0002196 | 93.91 | gold quality |
| heart | UBERON:0000948 | 93.90 | gold quality |
| cerebellar cortex | UBERON:0002129 | 93.86 | gold quality |
| right lobe of liver | UBERON:0001114 | 93.71 | gold quality |
| zone of skin | UBERON:0000014 | 93.56 | gold quality |
| leukocyte | CL:0000738 | 93.54 | gold quality |
| adrenal cortex | UBERON:0001235 | 93.33 | gold quality |
| upper lobe of lung | UBERON:0008948 | 93.22 | gold quality |
| saliva-secreting gland | UBERON:0001044 | 93.10 | gold quality |
| substantia nigra | UBERON:0002038 | 93.09 | gold quality |
| mouth mucosa | UBERON:0003729 | 93.05 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 93.02 | gold quality |
| spleen | UBERON:0002106 | 92.95 | gold quality |
| subcutaneous adipose tissue | UBERON:0002190 | 92.90 | gold quality |
| cerebellum | UBERON:0002037 | 92.89 | gold quality |
| forebrain | UBERON:0001890 | 92.74 | gold quality |
| pituitary gland | UBERON:0000007 | 92.64 | gold quality |
| stomach | UBERON:0000945 | 92.63 | gold quality |
| cerebral cortex | UBERON:0000956 | 92.58 | gold quality |
| thyroid gland | UBERON:0002046 | 92.49 | gold quality |
| uterine cervix | UBERON:0000002 | 92.48 | gold quality |
| brain | UBERON:0000955 | 92.39 | gold quality |
| right uterine tube | UBERON:0001302 | 92.37 | gold quality |
| ventricular zone | UBERON:0003053 | 92.19 | gold quality |
| left testis | UBERON:0004533 | 91.99 | gold quality |
| adrenal gland | UBERON:0002369 | 91.98 | gold quality |
| cortex of kidney | UBERON:0001225 | 91.87 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 9.17 |
| E-MTAB-7303 | no | 492.84 |
HPA expression
RNA tissue specificity: Low tissue specificity
showing 60 of 80 HPA tissues / cells by nTPM:
| Tissue / cell | Axis | nTPM | Protein (IHC) |
|---|---|---|---|
| Skeletal muscle | tissue | 139.0 | medium |
| Postcentral gyrus | tissue | 81.1 | |
| Vagina | tissue | 75.7 | medium |
| Hippocampus | tissue | 74.1 | high |
| Locus coeruleus | tissue | 71.8 | |
| Frontal cortex | tissue | 66.9 | |
| Nucleus accumbens | tissue | 63.4 | |
| Choroid plexus | tissue | 60.1 | |
| Pituitary gland | tissue | 52.3 | |
| Salivary gland | tissue | 42.6 | high |
| Adipose tissue | tissue | 41.6 | medium |
| Bone marrow | tissue | 40.2 | high |
| Tongue | tissue | 35.7 | |
| Caudate putamen | tissue | 35.3 | |
| Pancreas | tissue | 34.8 | high |
| Stomach 1 | tissue | 33.5 | high |
| Appendix | tissue | 30.2 | high |
| Heart muscle | tissue | 29.7 | medium |
| Spleen | tissue | 26.8 | high |
| Small intestine | tissue | 26.0 | medium |
| Adrenal gland | tissue | 25.3 | medium |
| Colon | tissue | 25.2 | high |
| Skin 1 | tissue | 25.0 | medium |
| Pons | tissue | 24.4 | |
| Duodenum | tissue | 24.0 | high |
| Ovary | tissue | 22.4 | medium |
| Thalamus | tissue | 22.4 | |
| Lymph node | tissue | 21.3 | high |
| Liver | tissue | 21.2 | medium |
| Seminal vesicle | tissue | 20.9 | high |
| Parathyroid gland | tissue | 20.8 | medium |
| Midbrain | tissue | 20.4 | |
| Superior colliculi | tissue | 20.3 | |
| Prostate | tissue | 20.3 | medium |
| Kidney | tissue | 20.2 | medium |
| Medulla oblongata | tissue | 20.1 | |
| Substantia nigra | tissue | 19.4 | |
| Placenta | tissue | 19.0 | medium |
| Cerebral cortex | tissue | 18.7 | high |
| Motor cortex | tissue | 18.7 | |
| Spinal cord | tissue | 18.7 | |
| Endometrium 1 | tissue | 18.6 | high |
| Hypothalamus | tissue | 18.6 | |
| Somatosensory cortex | tissue | 18.3 | |
| Lung | tissue | 18.2 | medium |
| Periaqueductal gray | tissue | 18.0 | |
| Prefrontal cortex | tissue | 16.6 | |
| Occipital cortex | tissue | 16.6 | |
| Putamen | tissue | 16.4 | |
| Thymus | tissue | 16.4 | |
| Cervix | tissue | 16.0 | high |
| Hippocampal formation | tissue | 16.0 | |
| Entorhinal cortex | tissue | 16.0 | |
| Temporal cortex | tissue | 15.9 | |
| Testis | tissue | 15.6 | high |
| Esophagus | tissue | 15.4 | medium |
| Retrosplenial cortex | tissue | 15.1 | |
| Urinary bladder | tissue | 15.0 | high |
| Retrosplenial and cingulate cortex | tissue | 14.9 | |
| Fallopian tube | tissue | 14.7 | high |
Brain sub-regions (HPA Brain Atlas): detected in 192; highest nTPM — Blood vessel (97.0), Posterior thalamic nucleus (87.0), Somatomor cortex, precentral gyrus (white matter) (86.7), Orbitofrontal gyrus, anterior (84.7), Lateral vestibular nucleus (84.0).
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
Targeting CCDC124 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific).
3 miRNAs:
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-138-5P | 98.43 | 70.49 | 1292 |
| HSA-MIR-3661 | 97.83 | 67.30 | 705 |
| HSA-MIR-10398-5P | 97.12 | 64.94 | 1051 |
Functional genomics
gnomAD constraint: pLI 0.0202, LOEUF 0.991, missense Z 0.19 — population loss-of-function intolerance (pLI ≥ 0.9 = LoF-intolerant; lower LOEUF = more constrained). gnomAD
Regional missense constraint (gnomAD RMC): no regional variation along ENST00000445755 — one region, missense o/e 0.89.
Literature-anchored findings (GeneRIF, showing 5)
- Ccdc124 is a novel factor operating both for proper progression of late cytokinetic stages in eukaryotes. (PMID:23894443)
- Structure and function of yeast Lso2 and human CCDC124 bound to hibernating ribosomes. (PMID:32687489)
- Coiled-coil domain-containing protein-124 (Ccdc124) is a novel RNA binding factor up-regulated in endometrial, ovarian, and urinary bladder cancers. (PMID:33896821)
- Dimerization underlies the aggregation propensity of intrinsically disordered coiled-coil domain-containing 124. (PMID:34369007)
- Live Cell Protein Imaging of Tandem Complemented-GFP11-Tagged Coiled-Coil Domain-Containing Protein-124 Identifies this Factor in G3BP1-Induced Stress-Granules. (PMID:39009911)
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | ccdc124 | ENSDARG00000043502 |
| mus_musculus | Ccdc124 | ENSMUSG00000007721 |
| rattus_norvegicus | Ccdc124 | ENSRNOG00000018932 |
| drosophila_melanogaster | CG6013 | FBGN0038675 |
| caenorhabditis_elegans | Y73E7A.1 | WBGENE00022268 |
Mouse-model phenotypes
Observed phenotypes of the mouse ortholog (MGI:1916403) from MGI (Alliance of Genome Resources) — knockout/mutant phenotypes, ranked by annotation count. 7 distinct phenotype terms.
| Mouse phenotype (MP) | Records |
|---|---|
| small liver | 1 |
| small spleen | 1 |
| decreased brain size | 1 |
| hyperactivity | 1 |
| decreased exploration in new environment | 1 |
| small heart | 1 |
| small lung | 1 |
Additional cross-species homologs
Sequence homologs in species beyond Ensembl Compara’s model organisms, by Diamond local protein alignment (% sequence identity; best hit per species). Lower-identity rows are more distant homologs. The matched accessions’ gene symbols aren’t in biobtree yet, so each row shows the UniProt accession.
| Organism | UniProt | Identity | Method |
|---|---|---|---|
| Pongo abelii | Q5R8X8 | 94.6% | Diamond |
| Bos taurus | Q2TBV6 | 88.8% | Diamond |
| Xenopus tropicalis | Q28HN4 | 86.1% | Diamond |
| Xenopus laevis | Q68EY7 | 86.1% | Diamond |
| Dictyostelium discoideum | Q54GW3 | 53.3% | Diamond |
| Schizosaccharomyces pombe 972h- | O94389 | 46.1% | Diamond |
Genomic neighbors (locus context)
Genes flanking this one on the chromosome (NCBI/Entrez gene neighborhood). Positional context only — some neighbors share regulatory elements (bidirectional promoters, antisense/overlapping transcripts), but chromosomal adjacency is not itself a functional relationship (see Interactions for that).
| Symbol | Type | Entrez |
|---|---|---|
| ARRDC2 | protein-coding | 27106 |
| KCNN1 | protein-coding | 3780 |
| SLC5A5 | protein-coding | 6528 |
| SNORA68 | snoRNA | 26780 |
| INSL3 | protein-coding | 3640 |
| JAK3 | protein-coding | 3718 |
| RPL18A | protein-coding | 6142 |
Protein
Protein identifiers
Coiled-coil domain-containing protein 124 — Q96CT7 (reviewed: Q96CT7)
All UniProt accessions (2): Q96CT7, M0R2F5
UniProt curated annotations — full annotation on UniProt →
Function. Ribosome-binding protein involved in ribosome hibernation: associates with translationally inactive ribosomes and stabilizes the nonrotated conformation of the 80S ribosome, thereby promoting ribosome preservation and storage. Also required for proper progression of late cytokinetic stages.
Subunit / interactions. Associates with translationally inactive ribosomes in the nonrotated state. Interacts with RASGEF1B.
Subcellular location. Cytoplasm. Cytoskeleton. Microtubule organizing center. Centrosome. Midbody.
Tissue specificity. Ubiquitously expressed.
Similarity. Belongs to the CCDC124 family.
RefSeq proteins (2): NP_001129675, NP_612451 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR010422 | Ccdc124/Oxs1 | Family |
| IPR054414 | Ccdc124/Oxs1_C | Domain |
Pfam: PF06244
UniProt features (13 total): helix 4, region of interest 2, compositionally biased region 2, modified residue 2, chain 1, coiled-coil region 1, sequence variant 1
Structure
Experimental structures (PDB)
6 structures by resolution:
| PDB | Title | Method | Resolution (Å) |
|---|---|---|---|
| 8K2C | Cryo-EM structure of the human 80S ribosome with Tigecycline | ELECTRON MICROSCOPY | 2.4 |
| 6ZM7 | SARS-CoV-2 Nsp1 bound to the human CCDC124-80S-EBP1 ribosome complex | ELECTRON MICROSCOPY | 2.7 |
| 9P9H | In situ human unrotated hibernating with CCDC124 state 80S ribosome | ELECTRON MICROSCOPY | 2.84 |
| 6Z6L | Cryo-EM structure of human CCDC124 bound to 80S ribosomes | ELECTRON MICROSCOPY | 3 |
| 6ZME | SARS-CoV-2 Nsp1 bound to the human CCDC124-80S-eERF1 ribosome complex | ELECTRON MICROSCOPY | 3 |
| 8XSY | Cryo-EM structure of the human 80S ribosome with Tigecycline, e-tRNA and CCDC124 (40S … | ELECTRON MICROSCOPY | 3 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q96CT7-F1 | 80.59 | 0.33 |
Human Protein Atlas
Protein class: Predicted intracellular proteins
Protein evidence: Evidence at protein level
Subcellular location (HPA, imaging): cytosol; plasma membrane
Antibody reliability (HPA): IH supported · IF enhanced
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (2)
| Type | Positions |
|---|---|
| Phosphoserine | 141, 194 |
Function
Pathways and Gene Ontology
Reactome pathways
0 curated (TAS) of 0; 0 disease pathways. Curated-first; evidence = TAS (manually curated) vs IEA (electronic inference).
MSigDB gene sets: 85 (showing top):
GOCC_MICROTUBULE_ORGANIZING_CENTER, GOCC_CENTROSOME, GOBP_CELL_DIVISION, GOCC_MIDBODY, chr19p13, GOMF_TRANSCRIPTION_COACTIVATOR_ACTIVITY, KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_DN, BRUINS_UVC_RESPONSE_EARLY_LATE, DELACROIX_RARG_BOUND_MEF, GOMF_TRANSCRIPTION_COREGULATOR_ACTIVITY, MYC_UP.V1_UP, CAMP_UP.V1_UP, GSE5503_MLN_DC_VS_SPLEEN_DC_ACTIVATED_ALLOGENIC_TCELL_DN, GSE14415_ACT_TCONV_VS_ACT_NATURAL_TREG_DN, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY
GO Biological Process (3): transcription by RNA polymerase II (GO:0006366), cell division (GO:0051301), positive regulation of DNA-templated transcription (GO:0045893)
GO Molecular Function (3): transcription coactivator activity (GO:0003713), RNA binding (GO:0003723), protein binding (GO:0005515)
GO Cellular Component (5): nucleus (GO:0005634), centrosome (GO:0005813), cytosol (GO:0005829), plasma membrane (GO:0005886), midbody (GO:0030496)
GO top-level categories
15 GO namespaces:
| Category | Terms |
|---|---|
| DNA-templated transcription | 2 |
| cellular anatomical structure | 2 |
| cellular process | 1 |
| regulation of DNA-templated transcription | 1 |
| positive regulation of RNA biosynthetic process | 1 |
| transcription coregulator activity | 1 |
| positive regulation of DNA-templated transcription | 1 |
| nucleic acid binding | 1 |
| binding | 1 |
| intracellular membrane-bounded organelle | 1 |
| centriole | 1 |
| microtubule organizing center | 1 |
| cytoplasm | 1 |
| membrane | 1 |
| cell periphery | 1 |
Experimentally-supported GO annotations
GO terms backed by direct experimental evidence (ECO experimental codes) — 3 of 11 annotations. The rest are phylogenetic / computational / electronic (IEA).
3 experimentally-supported GO terms:
| GO term | NS | Evidence |
|---|---|---|
| cytosol | CC | direct assay |
| plasma membrane | CC | direct assay |
| RNA binding | MF | high-throughput assay |
Protein interactions and networks
STRING
showing 15 of 1,318 interactions by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| CCDC124 | C5orf34 | Q96MH7 | 763 |
| CCDC124 | IFRD2 | Q12894 | 638 |
| CCDC124 | COPS8 | Q99627 | 629 |
| CCDC124 | SERBP1 | Q8NC51 | 578 |
| CCDC124 | HAAO | P46952 | 558 |
| CCDC124 | CCDC77 | Q9BR77 | 492 |
| CCDC124 | C19orf53 | Q9UNZ5 | 488 |
| CCDC124 | AURKAIP1 | Q9NWT8 | 456 |
| CCDC124 | RDH12 | Q96NR8 | 436 |
| CCDC124 | TUBGCP2 | Q9BSJ2 | 433 |
| CCDC124 | EIF3J | O75822 | 429 |
| CCDC124 | PIK3R5 | Q8WYR1 | 429 |
| CCDC124 | CDK11B | P21127 | 416 |
| CCDC124 | FAM174C | Q9BVV8 | 387 |
| CCDC124 | RTRAF | Q9Y224 | 382 |
IntAct
Human interaction partners of CCDC124 in IntAct, one row per partner (best MIscore; records = supporting IntAct interaction records).
5 partners by confidence:
| Partner | Interaction type | MIscore | Records |
|---|---|---|---|
| NPM1 | colocalization | 0.650 | 6 |
| H1-1 | physical association | 0.400 | 1 |
| H2BC9 | physical association | 0.400 | 1 |
| MYH9 | physical association | 0.400 | 1 |
| ERBB2 | association | 0.350 | 1 |
BioGRID (153 interactions; top human partners by supporting records): ADARB1 (Affinity Capture-MS; 2 records), DCTN1 (Proximity Label-MS; 2 records), EZR (Proximity Label-MS; 2 records), PRKRA (Affinity Capture-MS; 2 records), RPL10 (Affinity Capture-MS; 2 records), AATF (Affinity Capture-MS), ABCE1 (Affinity Capture-MS), APEX1 (Co-fractionation), ATG13 (Affinity Capture-MS), ATG16L1 (Affinity Capture-MS), ATG4B (Affinity Capture-MS), ATOH1 (Affinity Capture-MS), BCOR (Affinity Capture-MS), BRD4 (Affinity Capture-MS), C7orf50 (Affinity Capture-MS)
Disease & clinical
Genetic variants
Variant evidence for CCDC124: 49 ClinVar records (0 pathogenic / likely pathogenic); 5 GWAS associations.
ClinVar
49 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 43 |
| Likely benign | 0 |
| Benign | 0 |
SpliceAI
Top 10 splice-impact sites by Δscore (adjacent positions with the same effect merged into one range; 23 predictions of 465):
| Position(s) | Effect | Δscore | Sites |
|---|---|---|---|
| 19:17936580 | donor_loss | 1.0000 | 2 |
| 19:17942654 | acceptor_loss | 1.0000 | 3 |
| 19:17942824 | donor_gain | 1.0000 | |
| 19:17942830 | donor_gain | 1.0000 | |
| 19:17943244 | acceptor_gain | 1.0000 | |
| 19:17943248 | acceptor_gain | 1.0000 | |
| 19:17943252–17943254 | acceptor_gain | 1.0000 | 2 |
| 19:17943259–17943260 | acceptor_loss | 1.0000 | 4 |
| 19:17943506–17943507 | acceptor_loss | 1.0000 | 2 |
| 19:17933049–17933050 | donor_loss | 0.9900 | 6 |
AlphaMissense
564 missense substitutions predicted likely pathogenic (of 1,461 scored), across 152 residues. Top 20 hotspot residues, ranked by the number of likely-pathogenic substitutions (of those reachable by a single-nucleotide change), then by mean score:
| Residue | Likely-pathogenic substitutions | Mean am_pathogenicity | Max am_pathogenicity |
|---|---|---|---|
| N9 | 8 | 0.979 | 0.996 |
| H164 | 8 | 0.969 | 0.995 |
| N210 | 8 | 0.962 | 0.997 |
| N131 | 8 | 0.960 | 0.993 |
| F5 | 8 | 0.924 | 0.995 |
| N133 | 8 | 0.894 | 0.985 |
| N213 | 8 | 0.845 | 0.984 |
| W204 | 7 | 0.993 | 0.999 |
| W39 | 7 | 0.987 | 0.996 |
| F176 | 7 | 0.986 | 0.997 |
| Q195 | 7 | 0.978 | 0.996 |
| F173 | 7 | 0.973 | 0.990 |
| E166 | 7 | 0.966 | 0.987 |
| M191 | 7 | 0.933 | 0.983 |
| D43 | 7 | 0.905 | 0.933 |
| E77 | 7 | 0.822 | 0.934 |
| E8 | 7 | 0.764 | 0.919 |
| K11 | 6 | 0.989 | 0.998 |
| P211 | 6 | 0.982 | 0.993 |
| K3 | 6 | 0.973 | 0.995 |
HPA cancer prognostics
RNA cancer specificity: Low cancer specificity
Human Protein Atlas survival analysis — favorable = higher expression predicts better survival.
1 prognostic cancer types:
| Cancer | Prognostic | p-value |
|---|---|---|
| Liver Hepatocellular Carcinoma (TCGA) | unfavorable | 3.84e-06 |
Disease associations
OMIM: gene MIM:621286 | disease phenotypes:
GWAS associations
5 associations:
| Study | Trait | p-value |
|---|---|---|
| GCST90002387_15 | Immature fraction of reticulocytes | 1e-14 |
| GCST90002385_263 | High light scatter reticulocyte count | 6e-13 |
| GCST90002386_607 | High light scatter reticulocyte percentage of red cells | 1e-12 |
| GCST90002385_264 | High light scatter reticulocyte count | 3e-11 |
| GCST90002386_217 | High light scatter reticulocyte percentage of red cells | 4e-11 |
EFO canonical traits (from GWAS)
1 canonical traits:
| EFO ID | Trait name |
|---|---|
| EFO:0007986 | reticulocyte count |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (CPIC guideline: no)
CTD chemical–gene interactions
24 total (human), top 24 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| sodium arsenite | decreases expression, increases expression | 3 |
| bisphenol A | decreases methylation, increases expression | 2 |
| Caffeine | decreases phosphorylation, increases expression | 2 |
| Valproic Acid | increases expression, increases methylation | 2 |
| Particulate Matter | decreases expression, decreases reaction, increases abundance | 2 |
| aristolochic acid I | increases expression | 1 |
| bisphenol F | increases expression | 1 |
| beauvericin | decreases expression | 1 |
| pyrogallol 1,3-dimethyl ether | affects cotreatment, decreases expression, affects localization, increases expression | 1 |
| beta-lapachone | increases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| K 7174 | decreases expression | 1 |
| bisphenol B | increases expression | 1 |
| 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide | decreases expression, decreases reaction | 1 |
| bisphenol AF | increases expression | 1 |
| Air Pollutants | decreases expression, increases abundance | 1 |
| Vehicle Emissions | decreases reaction, decreases expression | 1 |
| Furaldehyde | affects cotreatment, decreases expression, affects localization, increases expression | 1 |
| Ivermectin | decreases expression | 1 |
| Ribonucleotides | affects binding | 1 |
| Smoke | decreases expression | 1 |
| Sodium Chloride | decreases expression, affects localization, increases expression, affects cotreatment | 1 |
| Dronabinol | increases expression | 1 |
| Cyclosporine | increases expression | 1 |
Clinical trials (associated diseases)
Via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.